Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet complementary mechanisms of action. At Mateon, we believe that we can significantly improve cancer therapy by combining these 2 complementary approaches. When utilized this way, VDAs disrupt existing blood vessels in the tumor leading to significant central tumor cell death while AAs prevent the formation of new tumor blood vessels. We are committed to leveraging our intellectual property and the product development expertise of our highly skilled management team to enable VTT to realize its true potential and to bring much-needed new therapies to cancer patients worldwide.
View Top Employees from Mateon TherapeuticsWebsite | http://www.mateon.com/ |
Ticker | MATN |
Revenue | $16000 |
Funding | $1 million |
Employees | 3 (3 on RocketReach) |
Founded | 1996 |
Address | 701 Gateway Boulevard Suite 210, South San Francisco, California 94080, US |
Phone | (650) 635-7000 |
Fax | (650) 635-7001 |
Industry | Business Services, Biotechnology, Biotechnology Research, Science and Engineering, Health Care, Pharmaceuticals, Education, Pharmaceutical, Healthcare, Organizations |
Web Rank | 18 Million |
Keywords | Mateon |
Competitors | Biokine Therapeutics Ltd., Curemark, LLC, CymaBay Therapeutics, Metacrine, Inc., Onconova Therapeutics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies |
Looking for a particular Mateon Therapeutics employee's phone or email?
The Mateon Therapeutics annual revenue was $16000 in 2024.
Mike Potts is the Vice President of Data Science of Mateon Therapeutics.
3 people are employed at Mateon Therapeutics.
Mateon Therapeutics is based in South San Francisco, California.
The NAICS codes for Mateon Therapeutics are [54, 325, 5417, 32, 32541, 3254, 541].
The SIC codes for Mateon Therapeutics are [873, 87].